Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about obesity drugs

Recent news which mentions obesity drugs

GLP-1 Boom Sparks Potential 'Bubble Effect,' Shrinking Competition In Big Pharma, Warns Deloitte: 'The Question Is...'
Tickers KR LLY NEWS NVO
Tags Market News NVO Health Care
From Benzinga
Zepbound Put Eli Lilly On Top — Now Its Next Big Move Could Supercharge The Stock
Tickers LLY
Tags Benzinga obesity drugs glp/1
From Benzinga
EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs
Tickers NEWS VANI
Tags Stories That Matter Contracts General
From Benzinga
Eli Lilly Pumps $800M Into Irish Operations To Meet Skyrocketing Demand For Mounjaro, Zepbound
Tickers LLY NEWS
Tags News obesity drugs Benzinga
From Benzinga
EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year
Tickers NEWS NVO VANI
Tags Benzinga obesity drugs Market/Moving Exclusives
From Benzinga
Only 25% Patients Stick With Novo Nordisk's Wegovy Or Ozempic After 2 Years, A Study Shows; Company Calls Data Insufficient
Tickers LLY NEWS NVO
Tags Top Stories News obesity drugs
From Benzinga
Ozempic, Wegovy Other Weight-Loss Drugs Won't Solve Global Obesity Crisis Affecting 1B People, WHO Warns
Tickers LLY NEWS NVO
Tags Health Care NVO Market News
From Benzinga
Eli Lilly Soars On Diabetes And Obesity Drug Boom, Projects 20% Revenue Increase In 2024
Tickers LLY NEWS
Tags Weightloss drug obesity drugs Benzinga
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Tickers ALT EVS JNJ KVUE
Tags Market News ALT EVs
From Benzinga
Snacks In The Ozempic Era: Food, Beverage Stocks Crash With Weight Loss Drugs On The Rise
Tickers BRBR CAG CPB FOOD
Tags K TAP Movers
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.